LEP and lipodystrophy: Given the potent therapeutic effects of leptin replacement on glucose homeostasis and liver steatosis in lipodystrophic mice and humans6,7,28, we speculated whether elevated leptin levels might explain the apparent absence of lipodystrophy-associated metabolic dysfunction in iAKO mice.